SUIT-017: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{MitoPedia | {{MitoPedia | ||
|abbr= | |abbr=OXPHOS (F+G+S) | ||
|description=[[File:1OctM;2D;2c;3G;4S;5U;6Rot-.png |355px]] | |description=[[File:1OctM;2D;2c;3G;4S;5U;6Rot-.png |355px]] | ||
|info='''A:''' | |info='''A:''' | ||
}} | }} | ||
::: '''[[SUIT protocol pattern]]:''' 1OctM;2D;3G;4S;5U;6Rot- | |||
::: '''[[SUIT protocol pattern]]:''' | |||
SUIT-017 gives information on [[Fatty_acid_oxidation_pathway_control_state|F-pathway]] in [[LEAK-respiration#The_LEAK_state |LEAK state]] and [[Oxidative phosphorylation|OXPHOS state]] avoiding FAO overestimation in the presence of [[Anaplerosis|anaplerotic]] pathways. In addition, the pathway control of [[FN]] and [[FNS]] in [[Oxidative phosphorylation|OXPHOS state]] and of [[FNS]] and [[S]] in [[ET-capacity| ET state]] is evaluated. | SUIT-017 gives information on [[Fatty_acid_oxidation_pathway_control_state|F-pathway]] in [[LEAK-respiration#The_LEAK_state |LEAK state]] and [[Oxidative phosphorylation|OXPHOS state]] avoiding FAO overestimation in the presence of [[Anaplerosis|anaplerotic]] pathways. In addition, the pathway control of [[FN]] and [[FNS]] in [[Oxidative phosphorylation|OXPHOS state]] and of [[FNS]] and [[S]] in [[ET-capacity| ET state]] is evaluated. | ||
__TOC__ | __TOC__ | ||
ย Communicated by [[Doerrier C]], [[Huete-Ortega M]], [[Iglesias-Gonzalez J]] | ย Communicated by [[Doerrier C]], [[Huete-Ortega M]], [[Iglesias-Gonzalez J]], [[Gnaiger E]] (last update 2019-06-05) | ||
ย | |||
== Specific SUIT protocols == | == Specific SUIT protocols == | ||
=== SUIT-017 O2 pfi D049 === | === SUIT-017 O2 pfi D049 === | ||
[[File:1OctM;2D;2c;3G;4S;5U;6Rot;7Ama.png |400px]] | [[File:1OctM;2D;2c;3G;4S;5U;6Rot;7Ama.png |400px]] | ||
[[File:D046_O2_traces.png|400px]] | [[File:D046_O2_traces.png|400px]] | ||
*[[SUIT-017 O2 mt D046]] evaluation of fatty acids and Q-junction additivity in mitochondrial preparations (isolated mitochondria, tissue homogenate and permeabilized cells) | * [[SUIT-017 O2 mt D046]] evaluation of fatty acids and Q-junction additivity in mitochondrial preparations (isolated mitochondria, tissue homogenate and permeabilized cells) | ||
=== SUIT-017 O2 pfi D049 === | === SUIT-017 O2 pfi D049 === | ||
[[File:1OctM;2D;3G;4S;5U;6Rot;7Ama.png|400px]] | [[File:1OctM;2D;3G;4S;5U;6Rot;7Ama.png|400px]] | ||
[[File:D049_O2_traces.png|400px]] | [[File:D049_O2_traces.png|400px]] | ||
*[[SUIT-017 O2 pfi D049]] evaluation of fatty acids and Q-junction additivity in permeabilized fibers | * [[SUIT-017 O2 pfi D049]] evaluation of fatty acids and Q-junction additivity in permeabilized fibers | ||
{{Template:SUIT-017}} | {{Template:SUIT-017}} |
Revision as of 13:07, 5 June 2019
Description
Abbreviation: OXPHOS (F+G+S)
Reference: A:
- SUIT protocol pattern: 1OctM;2D;3G;4S;5U;6Rot-
SUIT-017 gives information on F-pathway in LEAK state and OXPHOS state avoiding FAO overestimation in the presence of anaplerotic pathways. In addition, the pathway control of FN and FNS in OXPHOS state and of FNS and S in ET state is evaluated.
Communicated by Doerrier C, Huete-Ortega M, Iglesias-Gonzalez J, Gnaiger E (last update 2019-06-05)
Specific SUIT protocols
SUIT-017 O2 pfi D049
- SUIT-017 O2 mt D046 evaluation of fatty acids and Q-junction additivity in mitochondrial preparations (isolated mitochondria, tissue homogenate and permeabilized cells)
SUIT-017 O2 pfi D049
- SUIT-017 O2 pfi D049 evaluation of fatty acids and Q-junction additivity in permeabilized fibers
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1OctM | OctML(n) | F(N) | FAO | 1OctM
Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. Low concentration of malate, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. Non-phosphorylating resting state (LEAK state); LEAK respiration L(n) in the absence of ADP, ATP, AMP (no adenylates). |
2D | OctMP | F(N) | FAO | 1OctM;2D
Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. Low concentration of malate, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. OXPHOS capacity P (with saturating [ADP]), active OXPHOS state. |
2c | OctMP | F(N) | FAO | 1OctM;2D;2c
Addition of cytochrome c yields a test for integrity of the mtOM (cytochrome c control efficiency). Stimulation by added cytochrome c would indicate an injury of the mtOM and limitation of respiration in the preceding state without added c due to loss of cytochrome c. Typically, cytochrome c is added immediately after the earliest ADP-activation step (OXPHOS capacity P with saturating [ADP]).Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. Low concentration of malate, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. OXPHOS capacity P (with saturating [ADP]), active OXPHOS state. |
3G | OctGMP | FN | F&CI | 1OctM;2D;2c;3G
NADH-linked substrates (type N-pathway to Q). Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. OXPHOS capacity P (with saturating [ADP]), active OXPHOS state. |
4S | OctGMSP | FNS | F&CI&II | 1OctM;2D;2c;3G;4S
Respiratory stimulation by simultaneous action of type N substrates & succinate, with convergent electron flow in the NS-pathway for reconstitution of TCA cycle function. Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. OXPHOS capacity P (with saturating [ADP]), active OXPHOS state. |
5U | OctGMSE | FNS | F&CI&II | 1OctM;2D;2c;3G;4S;5U
Respiratory stimulation by simultaneous action of type N substrates & succinate, with convergent electron flow in the NS-pathway for reconstitution of TCA cycle function. Respiratory stimulation of the FAO-pathway, F, by fatty acid, FA, in the presence of malate, M. Malate is a type N substrate (N), required for the F-pathway. The FA concentration has to be optimized to saturate the F-pathway, without inhibiting or uncoupling respiration. Noncoupled electron transfer state, ET state, with ET capacity E. |
6Rot | SE | S | CII | 1OctM;2D;2c;3G;4S;5U;6Rot
Succinate pathway control state (S-pathway) after inhibiting CI with rotenone, which also inhibits the F-pathway. Noncoupled electron transfer state, ET state, with ET capacity E. |
7Ama | ROX | 1OctM;2D;2c;3G;4S;5U;6Rot;7Ama
Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration. |
Step | Respiratory state | Pathway control | ET-Complex | Comment |
---|---|---|---|---|
## AsTm | AsTmE | CIV | CIV | |
## Azd | CHB |
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary
Strengths and limitations
- Comparison of GM- with PM-capacity yields important information on N-pathway respiratory control upstream of CI (Lemieux et al. 2017; Votion et al. 2012).
- + Glutamate is easier to prepare compared to pyruvate.
- + Reasonable duration of the experiment.
- + This protocol can be extended with the Complex IV module, which can prolong the experimental time by ~30 min.
Compare SUIT protocols
References
Year | Reference | Organism | Tissue;cell | |
---|---|---|---|---|
Pesta 2012 Methods Mol Biol | 2012 | Pesta D, Gnaiger E (2012) High-resolution respirometry. OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 810:25-58. https://doi.org/10.1007/978-1-61779-382-0_3 | Human | Skeletal muscle Other cell lines HEK Fibroblast HUVEC |
MitoPedia concepts: MiP concept, SUIT protocol, Recommended
MitoPedia methods:
Respirometry